Tanneisha Barlow, MD
Obstetrics & Gynecology · Raleigh, NCNPI 1558340190
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Intuitive Surgical at 52.5% of the total. Reporting peaked in 2021 at $7,556 and has fallen 85.1% since, to $1,125 in 2025. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 339 payments — averaging $38.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Bayer$695
- Pfizer$556
- Astellas Pharma US Inc$518
- Mayne Pharma Commercial LLC$438
- AbbVie$426
- plus $4K from 40 others
Across 2 payments — averaging $4402.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$6K
- Cepheid$2K
What the payments were for
- Travel & lodging$5945%
- Food & beverage$6,19748%
- Education$6,15348%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,663
- OVA1$167
How this compares
$12,945 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $1,553 |
| Estradiol (Twice Weekly)Estradiol | 18 | $1,548 |
| Ibandronate Sodium | 14 | $330 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Raleigh
- Jack IngeRaleigh$157K
- Robert LittletonRaleigh$61K
- Elizabeth CovielloRaleigh$26K
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.